D
Cytokinetics, Incorporated CYTK
$43.26 -$0.62-1.41%
Recommendation
Sell
Prev Close
$43.88
Volume
454,688
Avg Vol (90D)
1,393,157
Market Cap
$5.20B
Dividend & Yield
--
52-Week Range
$40.53 - $75.71
P/E (TTM)
--
EPS (TTM)
-$5.28
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
B. Riley Predicts Cytokinetics' Q1 Earnings (NASDAQ:CYTK)
3/6/2025 - Ticker Report
Insider Sell Alert: Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
3/6/2025 - GuruFocus
Insider Sell: Andrew Callos Sells Shares of Cytokinetics Inc (CYTK)
3/6/2025 - GuruFocus
Cytokinetics (CYTK, $43.69) Stochastic Oscillator left the oversold zone on March 04, 2025
3/5/2025 - Tickeron - Stocks
These Analysts Think Cytokinetics, Incorporated's (NASDAQ:CYTK) Sales Are Under Threat
3/5/2025 - Simply Wall St
Insider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)
3/4/2025 - GuruFocus
Cytokinetics (CYTK, $42.89) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 3, 2025
3/4/2025 - Tickeron - Stocks
Cytokinetics Inc (CYTK) Announces Participation in Key Investor Conferences
3/3/2025 - GuruFocus
Cytokinetics to Participate in March Investor Conferences
3/3/2025 - GuruFocus
Cytokinetics to Participate in March Investor Conferences
3/3/2025 - Globe Newswire
Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), Warby Parker (WRBY) and 89bio (ETNB)
3/3/2025 - TipRanks Financial Blog
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), DENTSPLY SIRONA (XRAY) and Cytokinetics (CYTK)
3/3/2025 - TipRanks Financial Blog
Brokers Set Expectations for Cytokinetics Q1 Earnings
3/3/2025 - MarketBeat
Cytokinetics, Incorporated (NASDAQ:CYTK) Just Reported And Analysts Have Been Cutting Their Estimates
3/2/2025 - Simply Wall St
Cytokinetics (NASDAQ:CYTK) Shares Gap Down - Here's What Happened
3/1/2025 - MarketBeat
HC Wainwright Reaffirms Buy Rating for Cytokinetics (NASDAQ:CYTK)
3/1/2025 - MarketBeat
Cytokinetics (CYTK, $46) price exceeded its 50-day Moving Average on February 28, 2025
3/1/2025 - Tickeron - Technical Analysis
Cytokinetics' Earnings Call: Progress Amid Challenges
3/1/2025 - TipRanks Financial Blog
Cytokinetics (NASDAQ:CYTK) Posts Earnings Results, Beats Expectations By $0.03 EPS
3/1/2025 - MarketBeat
Cytokinetics Q4 Loss Wider Than Expected, Aficamten in Focus
2/28/2025 - Zacks Investment Research
Cytokinetics Inc (CYTK) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses
2/28/2025 - GuruFocus
Decoding Cytokinetics Inc (CYTK): A Strategic SWOT Insight
2/28/2025 - GuruFocus
Q4 2024 Cytokinetics Inc Earnings Call Transcript
2/28/2025 - GuruFocus
Cytokinetics (NASDAQ:CYTK) Issues Earnings Results
2/28/2025 - Ticker Report
Cytokinetics, Incorporated (CYTK) Q4 2024 Earnings Call Transcript
2/28/2025 - SeekingAlpha
Income Statement
Total Revenue (TTM)
$18.47M
EBITDA (TTM)
-$526.72M
EBIT (TTM)
-$536.25M
Net Income (TTM)
-$589.53M
Balance Sheet
Total Assets (Q)
$1.40B
Total Debt (Q)
$923.18M
Total Liabilities (Q)
$1.54B
Book Value Per Share (Q)
-$1.15
Cash Flow
Cash from Operations (TTM)
-$395.89M
Cash from Investing (TTM)
-$553.10M
Cash from Financing (TTM)
$930.61M
Net Change in Cash (TTM)
-$18.17M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.04
7-Day Total Return
-7.27%
30-Day Total Return
-7.60%
60-Day Total Return
-14.17%
90-Day Total Return
-18.44%
Year to Date Total Return
-11.59%
1-Year Total Return
-35.32%
2-Year Total Return
10.55%
3-Year Total Return
17.46%
5-Year Total Return
200.42%
52-week Low
Feb 12, 2025 - $40.53
52-week High
Apr 09, 2024 - $75.71
Valuation
Market Cap
$5.20B - Mid Cap
Enterprise Value
$5.04B
Price/Sales (TTM)
280.56
Price/Book (Q)
-38.32
Dividends and Shares
Shares Outstanding
118.08M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.cytokinetics.com
Phone Number
650 624 3000
Address
350 Oyster Point Boulevard
South San Francisco, CA 94080
Country
United States
Year Founded
1997
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for... more
NASDAQ 03/06/2025 2:01PM Eastern Quotes delayed
Weiss Ratings